Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Li, Xinguo"'
Autor:
Huang, Xiaoyuan, Liang, Jing, Huang, Lili, Nian, Xuanxuan, Chen, Wei, Zhang, Jiayou, Xu, Xiao, Lin, Xuan, Wang, Yue, Shi, Jinrong, Jia, Lanxin, Li, Qingliang, Wang, Qianxi, Duan, Kai, Li, Xinguo, Ji, Yaqi, Peng, Feixia, Zhang, Wei, Xie, Zhiqiang, Wang, Yanxia, Yang, Xiaoming
This phase III clinical trial aimed to assess the safety and demonstrate the immunogenicity of a candidate freeze-dried purified Vero cell-based rabies vaccine (PVRV-WIBP) developed for human use. A cohort of 40 participants in stage 1 and 1956 subje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be93ee9a65bfb366a9b8889078d0313c
Autor:
Huang X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Liang J; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Huang L; Henan Provincial Center for Disease Control and Prevention, Zhengzhoa, China., Nian X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Chen W; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Zhang J; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Xu X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Lin X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Wang Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Shi J; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Jia L; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Li Q; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Wang Q; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Duan K; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Li X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Ji Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Peng F; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; Wuhan Institute of Biological Products Co. Ltd., Wuhan, China., Zhang W; Henan Provincial Center for Disease Control and Prevention, Zhengzhoa, China., Xie Z; Henan Provincial Center for Disease Control and Prevention, Zhengzhoa, China., Wang Y; Henan Provincial Center for Disease Control and Prevention, Zhengzhoa, China., Yang X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.; China National Biotech Group Company Limited, Beijing, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2211896. Date of Electronic Publication: 2023 May 30.
Autor:
Zeng Y; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Liu X; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Li Y; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Lu J; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Wu Q; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Dan D; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Lv S; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Xia F; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Hu C; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Li J; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Zhang H; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Du H; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Jia R; China National Biotec Group (CNBG), Beijing, People's Republic of China., Duan K; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Wang Z; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Li X; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Yang X; China National Biotec Group (CNBG), Beijing, People's Republic of China.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2208682.
Autor:
Fan R; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China., Huang X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Nian X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Ou Z; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China., Zhou J; Gaozhou Center for Disease Control and Prevention, Gaozhou, China., Zhang J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Zeng P; Gaozhou Center for Disease Control and Prevention, Gaozhou, China., Zhao W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Deng J; Gaozhou Center for Disease Control and Prevention, Gaozhou, China., Chen W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Chen S; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China., Duan K; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Chen Y; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China., Li X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China., Zhang J; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, China., Yang X; National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.; China National Biotec Group Company Limited, Beijing, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-9. Date of Electronic Publication: 2021 Sep 02.
Autor:
Huang X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Fan T; Shanxi Provincial Centers for Disease Control and Prevention, Taiyuan, Shanxi, China., Li L; Chaoyang Center for Disease Control and Prevention, Taiyuan, Shanxi, China., Nian X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Zhang J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Gao X; Shanxi Provincial Centers for Disease Control and Prevention, Taiyuan, Shanxi, China., Zhao W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Chen W; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Zhang Z; Qinyuan County Center for Disease Control and Prevention, Taiyuan, Shanxi, China., Yao Z; Qinyuan County Center for Disease Control and Prevention, Taiyuan, Shanxi, China., Han X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Shi J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Wang Y; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Bian H; Quwo County Center for Disease Control and Prevention, Taiyuan, Shanxi, China., Shi N; Chaoyang Center for Disease Control and Prevention, Taiyuan, Shanxi, China., Li X; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Duan K; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China., Li G; Shanxi Provincial Centers for Disease Control and Prevention, Taiyuan, Shanxi, China., Yang X; National Engineering Technology Research Center of Combined Vaccines, Wuhan, Hubei, China.; China National Biotec Group Company Limited, Beijing, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2079924. Date of Electronic Publication: 2022 Jun 17.
Autor:
Chen J; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Jin P; Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China., Chen X; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Mao Q; Division of Hepatitis virus and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China., Meng F; Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China., Li X; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Chen W; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Du M; Department of Disease Prevention and Control, Pei County Center for Disease Control and Prevention, Pei County, Jiangsu, China., Gao F; Division of Hepatitis virus and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China., Liu P; School of Public Health, Southeast University, Nanjing, Jiangsu, China., Li X; Department of Disease Prevention and Control, Pei County Center for Disease Control and Prevention, Pei County, Jiangsu, China., Guo C; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Xie T; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Lu W; Department of Research and Development, National Vaccine & Serum Institute, Beijing, China., Li Q; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Li L; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Yan X; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Guo X; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Du H; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Li X; Department of Research and Development, Shanghai Institute of Biological Products Co., Ltd, Shanghai, China., Duan K; Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China., Zhu F; Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2063630. Date of Electronic Publication: 2022 Jun 17.
Autor:
Zhao J; Department of Cardiovascular Medicine, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China., He X; Department of Cardiovascular Medicine, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China., Zuo M; Department of Cardiovascular Medicine, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China., Li X; Department of Cardiovascular Medicine, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China., Sun Z; Department of Cardiology, The Fourth People's Hospital of Shaanxi, Xi'an, Shaanxi, China.
Publikováno v:
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 3968-3977.
Autor:
Li X; Department of Neurosurgery, The First Hospital of China Medical University , Shenyang, People's Republic of China., Tong J; Department of Gastroenterology, The First Hospital of China Medical University , Shenyang, People's Republic of China., Liu J; Department of Neurosurgery, The First Hospital of China Medical University , Shenyang, People's Republic of China., Wang Y; Department of Neurosurgery, The First Hospital of China Medical University , Shenyang, People's Republic of China.
Publikováno v:
Bioengineered [Bioengineered] 2020 Dec; Vol. 11 (1), pp. 779-790.